European Committee for Treatment & Research in Multiple Sclerosis

Startseite
Schweiz
Basel
European Committee for Treatment & Research in Multiple Sclerosis

The European Committee for Treatment & Research in Multiple Sclerosis - the world's largest organisat

SAVE THE DATE: MSMilan2023, the 9th joint ECTRIMS-ACTRIMS meeting, will be held as a hybrid event on 11–13 October in Milan, Italy

10/11/2025

👀 New MS : Optic Nerve Assessment in MS

The optic nerve has become the fifth anatomical location in the 2024 revisions of the McDonald criteria for MS. Why is it of particular interest and how can it be assessed?

Read it here: https://ectrims.eu/insights/redefining-diagnostic-boundaries-optic-nerve-assessment-in-ms/

Featured in this month's article:

➡️ Shiv Saidha of Johns Hopkins University tells us, "Almost everybody is familiar with MRI. There is perhaps less familiarity with OCT. OCT is quick, inexpensive, and easy to repeat. With a resolution of approximately 3–5 microns, it provides an almost virtual biopsy of the retina."

➡️ Jeffrey Cohen of Cleveland Clinic Mellen Center for MS Treatment and Research adds, "The visual system is frequently affected in MS. Both the afferent and efferent visual pathways are involved in the disease process. Vision plays a crucial role in daily functioning, and its impairment can have a profound impact on an individual’s ability to work and overall quality of life."

07/11/2025

| Beyond the Congress

Stay connected with the science that shaped this year’s congress. The Best of Slide Deck brings together the most highly rated abstracts—covering clinical aspects, pathogenesis, therapy, imaging & biomarkers, plus a dedicated track on RiMS - Rehabilitation in Multiple Sclerosis.

Accessible anytime via myECTRIMS, our platform that supports continuous learning and collaboration within the MS community.

📥 Discover and share today ➡️ https://my.ectrims.eu/bestofslidedecks

06/11/2025

🚀 Apply now for the 2026 ECTRIMS Fellowship Programmes!
You have until 1 December to send in your application — so there’s still time to perfect it! ➡️ https://ectrims.eu/fellowships

🎓 Clinical Fellowship: Acquire specialised skills, collaborate with academia & industry leaders, and propel your clinical career to new heights.

🎓 Research Fellowship: Lead groundbreaking research, contribute to medical advancements, and become a thought leader in your domain.

🎓 Nurses & AHP Professionals Training: Elevate your expertise, enhance patient care, and open doors to diverse career opportunities.

🎓 MAGNIMS-ECTRIMS Fellowship: Use cutting-edge magnetic resonance techniques to advance your expertise in multiple sclerosis studies.

🎓 MEDEN-ECTRIMS Fellowship: Gain invaluable clinical experience in neuromyelitis optica spectrum disorders ( ) and myelin oligodendrocyte glycoprotein antibody-associated disorder ( ).

05/11/2025

🎥 Discover the future of at !

✨ Session 13: Emergent Therapies in MS & Related Conditions — leading experts share breakthrough findings & next-gen approaches in MS, MOGAD & NMOSD.

▶️ Watch now: https://ectrims-congress.virtual-meeting.org/programme/session/67942

05/11/2025

🎥 Explore the future of MS treatment in one of the most forward-looking sessions from !

✨ Scientific Session 13: Emergent Therapies in MS and Related Conditions

This session brought together leading experts to present breakthrough findings and next-generation approaches in MS, MOGAD, and NMOSD management.

Key highlights included:

• BTK inhibitors: evidence and expectations — Heinz Wiendl from Universitätsklinikum Freiburg
• RIPK1 inhibitor SAR443820 in MS: biomarker and safety outcomes — Xavier Montalban from CEMCAT (Centre d'Esclerosi Múltiple de Catalunya)
• Fenebrutinib maintains low disease activity in RMS: 2-year FENopta data — Jiwon Oh from University of Toronto

▶️ Watch the replay now: https://ectrims-congress.virtual-meeting.org/programme/session/67942

Not registered yet? Don’t miss the opportunity to access this session and 100+ more featuring world-leading experts and groundbreaking science.

Register today ➡️ https://bit.ly/46rMFZU

03/11/2025

Join our upcoming Clinical Case NeuroWebinar — free registration now open!

In this interactive session, our expert panel will explore one of the most intriguing challenges in MS management:
How should we approach treatment when patients remain clinically and radiologically stable, yet show persistently elevated NfL levels?

🧠 Rina Demjaha from Medizinische Universität Graz will open with a detailed case study of a 40-year-old MS patient who remains clinically stable on platform therapy and shows no new MRI activity, yet presents with consistently elevated serum NfL levels — prompting key questions about treatment adequacy.

🔍 Michael Khalil from Medizinische Universität Graz will then guide us through the decision-making process in such complex situations, discussing the implications of persistent NfL elevation and whether continued monitoring or treatment modification is the best course of action.

💬 Participants will have the opportunity to submit questions and engage in a live exchange with our panelists.

📅 12 November 2025
🕕 18:00-19:00 CET

Register for free via myECTRIMS 👉 https://my.ectrims.eu/webinars/110

31/10/2025

🌱 Ready to take the next step in your career?
Apply now for the 2026 ECTRIMS Fellowship Programmes!
You have until 1 December to send in your application — so there’s still time to perfect it! ➡️ https://ectrims.eu/fellowships

🎓 Clinical Fellowship: Acquire specialised skills, collaborate with academia & industry leaders, and propel your clinical career to new heights.

🎓 Research Fellowship: Lead groundbreaking research, contribute to medical advancements, and become a thought leader in your domain.

🎓 Nurses & AHP Professionals Training: Elevate your expertise, enhance patient care, and open doors to diverse career opportunities.

🎓 MAGNIMS-ECTRIMS Fellowship: Use cutting-edge magnetic resonance techniques to advance your expertise in multiple sclerosis studies.

🎓 MEDEN-ECTRIMS Fellowship: Gain invaluable clinical experience in neuromyelitis optica spectrum disorders ( ) and myelin oligodendrocyte glycoprotein antibody-associated disorder ( ).

30/10/2025

“There’s a lot of attention paid to the physical symptoms of MS... but in terms of mental health, we’re probably still lagging behind.” – Dr. Rebecca MaGuire

🎙️ As we wrap this month’s focus on International Depression Awareness, this episode of the ECTRIMS Podcast shines a light on why mental health — including depression, anxiety, loneliness, and stigma — must be central to conversations about MS care.

Rebecca MaGuire from Maynooth University shares both research insights and her personal experience of living with MS, and shines a spotlight on how clinicians and communities can foster more open, supportive environments for people living with the condition.

🎧 Listen now:

▶️ Spotify https://bit.ly/47OAXcg
▶️ Apple https://apple.co/4qOqQvM

MStranslate

28/10/2025

🎥 Rewatch one of the most dynamic sessions from !

✨ Scientific Session 17: Late-Breaking Abstracts

Catch the latest breakthroughs in MS and related disorders, featuring cutting-edge clinical trial results and next-generation therapies.

Key highlights include:

• Ocrelizumab vs placebo in primary progressive MS (ORATORIO-HAND) — Gavin Giovannoni from Queen Mary University of London

• High-dose vs standard-dose ocrelizumab in PPMS (GAVOTTE Study) — Stephen Hauser from UCSF

• Ocrelizumab vs fingolimod in paediatric RRMS (OPERETTA 2) — Brenda Banwell from Johns Hopkins University

▶️ Watch the replay now: https://ectrims-congress.virtual-meeting.org/programme/session/67943

Not registered yet? It’s not too late! Gain access to this session and 100+ more groundbreaking talks, posters, and educational resources.

Register today ➡️ https://bit.ly/46rMFZU

27/10/2025

Don’t miss our webinar today — learn how DMTs and rehabilitation can go hand in hand to improve life with MS!

While DMTs target inflammation and reduce relapses, rehabilitation helps restore and preserve brain function and everyday abilities.

Organised in collaboration with RiMS - Rehabilitation in Multiple Sclerosis, this webinar explores how rehabilitation and DMTs can work in harmony to slow MS progression, enhance neurological reserve, improve quality of life, and support a brain-healthy state.

Hear from our panel of experts:
- Prof. Peter Heys of Universal Hasselt
- Prof. Emilio Portaccio of Università degli Studi di Firenze
- Prof. Michelle Ploughman of Memorial University, Newfoundland and Labrador
- Prof. Ulrik Dalgas of Aarhus University
📅 27 October 2025, 18:00-19:00 CET

Register here for free 👉 https://bit.ly/46PDZg9

24/10/2025

In case you missed it! Patient Community Day 2025 recordings are available in English and Spanish.

Recap the sessions that brought together people living with multiple sclerosis and related neurological diseases, their caregivers, patient advocates, and experts working at the cutting edge of MS treatment and care.

▶️ Watch the discussions here: https://www.ectrimspatientcommunity.eu/

23/10/2025

| Beyond the Congress

Knowledge doesn’t stop when the sessions end. Our Best of Slide Deck is now available—an easy-to-access resource featuring top-rated abstracts across clinical aspects, pathology and pathogenesis, imaging and non-imaging biomarkers, therapy, and a special track on RiMS (Rehabilitation in Multiple Sclerosis).

Designed for quick reference and ongoing collaboration, this collection brings the highlights of Barcelona straight to you—wherever you are.

📥 Explore the key findings and share them within your networks via myECTRIMS ➡️ https://my.ectrims.eu/bestofslidedecks

Adresse

Reinacherstrasse 131
Basel
4053

Telefon

+41616867777

Webseite

http://www.ectrims.eu/

Benachrichtigungen

Lassen Sie sich von uns eine E-Mail senden und seien Sie der erste der Neuigkeiten und Aktionen von European Committee for Treatment & Research in Multiple Sclerosis erfährt. Ihre E-Mail-Adresse wird nicht für andere Zwecke verwendet und Sie können sich jederzeit abmelden.